Clinical Trials Browser

Phase NA × INDUSTRY × Leukemia, Myeloid, Acute × Clear all

NCT06572982 2026-01-14

Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients

Phase NA Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05260203 2024-11-06

MargheRITA

Phase NA Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT05943314 2023-11-02

Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia

Phase NA Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05801835 2023-09-21

A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04158726 2022-01-18

Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia

Phase NA Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05017883 2021-11-04

TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04920500 2021-06-09

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04692948 2021-03-08

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03152526 2020-07-09

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

Phase NA Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00088543 2015-03-18

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Phase NA Completed

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma